Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Caitrin Fretham"'
Autor:
Mary M. Horowitz, Bronwen E. Shaw, J. Douglas Rizzo, Stephanie J. Lee, Marcie L. Riches, Steven M. Devine, Wael Saber, Marcelo C. Pasquini, Patricia Steinert, Parameswaran Hari, Mary Eapen, Caitrin Fretham, Mehdi Hamadani, J. Brunner, Waleska S. Pérez, Stephen R. Spellman, Daniel J. Weisdorf, Saurabh Chhabra, Rachel Phelan, Anita D'Souza, Mukta Arora
Publikováno v:
Transplantation and Cellular Therapy. 28:715-716
Autor:
Sergio Giralt, Thuy T. Koll, Rebecca L. Olin, Marcelo C. Pasquini, Uday R. Popat, Richard J. Lin, Daniel J. Weisdorf, Andrew S. Artz, Mukta Arora, Benjamin A. Derman, Li-Wen Huang, Sang Mee Lee, Vijaya Raj Bhatt, Linda Pang, Caitrin Fretham
Publikováno v:
Blood Advances. 4:2810-2820
Use of allogeneic hematopoietic cell transplantation (alloHCT) is increasing in older patients with hematologic malignancies. Studies suggest that geriatric assessment (GA), incorporating functional measures such as instrumental activities of daily l
Autor:
Narendranath Epperla, Ang Li, Brent Logan, Caitrin Fretham, Saurabh Chhabra, Mahmoud Aljurf, Lynette Chee, Edward Copelan, César O. Freytes, Peiman Hematti, Hillard M. Lazarus, Mark Litzow, Taiga Nishihori, Richard F. Olsson, Tim Prestidge, Wael Saber, Baldeep Wirk, Jean A. Yared, Alison Loren, Marcelo Pasquini, Allistair A. Abraham, Vaibhav Agrawal, Medhat Askar, Pere Barba, Alice Bertaina, Jean‐Yves Cahn, Jan Cerny, Hannah K. Choe, Miguel Angel Diaz, Christopher Dvorak, Nosha Farhadfar, Shahinaz M. Gadalla, Usama Gergis, Siddhartha Ganguly, Shahrukh Hashmi, Kimberly A. Kasow, Sunita Nathan, Roomi Nusrat, Sachiko Seo, Niketa C. Shah
Publikováno v:
British Journal of Haematology. 189:1171-1181
Transplant-associated thrombotic microangiopathy (TA-TMA) is a complication of allogeneic transplantation (allo-HCT). The incidence and risk factors associated with TA-TMA are not well known. A retrospective analysis from the Center for International
Autor:
Leona Holmberg, Lori Muffly, Alison W. Loren, Miguel-Angel Perales, Usama Gergis, Tao Wang, Christopher A. Barker, Betty K. Hamilton, Allistair Abraham, Peiman Hematti, Miguel Angel Diaz, Eva C. Guinan, Edward A. Stadtmauer, Sanghee Hong, Jeffery J. Auletta, Gerhard C. Hildebrandt, Marcelo C. Pasquini, Christopher Bredeson, Siddhartha Ganguly, Shin Mineishi, Shahrukh K. Hashmi, Caitrin Fretham, Robert Peter Gale, Hillard M. Lazarus, Jean-Yves Cahn, Kehinde Adekola, Jean A. Yared, Natasha Kekre, Cesar O. Freytes, Saurabh Chhabra, Taiga Nishihori, Rodrigo Martino, Amer Beitinjaneh, Mitchell Sabloff
Publikováno v:
Biol Blood Marrow Transplant
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Malignancy relapse is the most common cause of treatment failure among recipients of hematopoietic cell transplantation (HCT). Conditioning dose intensity can reduce disease relapse but is offset by toxicities. Improvements in radiotherapy techniques
Autor:
Mohamed A. Kharfan-Dabaja, Leo F. Verdonck, Tania Jain, Gregory A. Hale, Navneet S. Majhail, Baldeep Wirk, Caitrin Fretham, Mahmoud Aljurf, Hemant S. Murthy, Kwang Woo Ahn, Ulrike Bacher, Wael Saber, Bart L. Scott, Jean Yves-Cahn, Daniel J. Weisdorf, Nosha Farhadfar, Richard F. Olsson, Michael R. Grunwald, Amer Beitinjaneh, Bipin N. Savani, Christopher Bredeson, Mark R. Litzow, Shatha Farhan, Jean A. Yared, Sachiko Seo, Jeff Szer, Gerhard C. Hildebrandt, Jan Cerny, David A. Rizzieri, Mitchell Sabloff, Ran Reshef, Vaibhav Agrawal, Robert Peter Gale, Ryotaro Nakamura, Saurabh Chhabra, Attaphol Pawarode, Taiga Nishihori, David I. Marks, Uday R. Popat, Siddhartha Ganguly, Miguel Angel Diaz, Betul Oran, Matt Kalaycio, Edward A. Copelan, Asad Bashey, Hillard M. Lazarus, Jane L. Liesveld, Shahrukh K. Hashmi, Marjolein van der Poel, Sunita Nathan
Publikováno v:
Transplantation and Cellular Therapy, 27(11). Elsevier
Reduced-intensity conditioning (RIC) regimens developed to extend the use of allogeneic hematopoietic stem cell transplantation (HSCT) to older patients have resulted in encouraging outcomes. We aimed to compare the 2 most commonly used RIC regimens,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d6a14a48b561685478be682fe7d726
https://cris.maastrichtuniversity.nl/en/publications/3af6c0ea-79ff-47be-b3cc-a5349bd89b26
https://cris.maastrichtuniversity.nl/en/publications/3af6c0ea-79ff-47be-b3cc-a5349bd89b26
Autor:
Adam S. Nelson, Ann E. Woolfrey, Nancy Bunin, Andrew S. Artz, Larisa Broglie, David A. Jacobsohn, Shin Mineishi, Joanne Kurtzberg, Marcelo C. Pasquini, Caitrin Fretham, Lauri Burroughs, Alison W. Loren, Brent R. Logan, Mohamed L. Sorror, Monica S. Thakar, Caridad Martinez
Publikováno v:
Blood. 133:754-762
Despite improvements, mortality after allogeneic hematopoietic cell transplantation (HCT) for nonmalignant diseases remains a significant problem. We evaluated whether pre-HCT conditions defined by the HCT Comorbidity Index (HCT-CI) predict probabili
Autor:
Gerhard C. Hildebrandt, Hillard M. Lazarus, Peiman Hematti, Asad Bashey, Maxwell M. Krem, David I. Marks, Stefanie W. Benoit, Siddhartha Ganguly, Shahrukh K. Hashmi, Tim Prestidge, Anita D'Souza, Christopher Bredeson, Tao Wang, Taiga Nishihori, Richard F. Olsson, Cesar O. Freytes, John R. Wingard, Edgar A. Jaimes, Saurabh Chhabra, Shahinaz M. Gadalla, Marcelo C. Pasquini, Larisa Broglie, Hemant S. Murthy, Bipin N. Savani, Caitrin Fretham, Lynette C.Y. Chee, Edward A. Stadtmauer, Amer Beitinjaneh, Mohamed L. Sorror, Jean A. Yared, Robert Peter Gale, Ajoy Dias, Nosha Farhadfar, David A. Rizzieri, A. Samer Al-Homsi
Publikováno v:
Transplant Cell Ther
Renal dysfunction is a recognized risk factor for mortality after allogeneic hematopoietic cell transplantation (alloHCT), yet our understanding of the effect of different levels of renal dysfunction at time of transplantation on outcomes remains lim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b2eb5d7090275ee7d5cb29f637af191
https://europepmc.org/articles/PMC8168834/
https://europepmc.org/articles/PMC8168834/
Autor:
Anita D'Souza, Caitrin Fretham, Stephanie J Lee, Mukta Arora, Janet Brunner, Saurabh Chhabra, Steven Devine, Mary Eapen, Mehdi Hamadani, Parameswaran Hari, Marcelo C Pasquini, Waleska Perez, Rachel A Phelan, Marcie L Riches, J Douglas Rizzo, Wael Saber, Bronwen E Shaw, Stephen R Spellman, Patricia Steinert, Daniel J Weisdorf, Mary M Horowitz
Publikováno v:
Biol Blood Marrow Transplant
Hematopoietic cell transplantation (HCT) is a well-established treatment to control and/or cure many malignant and non-malignant diseases involving the hematopoietic system and some solid tumors. We report information about HCT procedures performed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a01f19ef419b5f98babf658340de12a
https://europepmc.org/articles/PMC7404814/
https://europepmc.org/articles/PMC7404814/
Autor:
Caitrin Fretham, Mahmoud Aljurf, Marcelo C. Pasquini, Edward A. Copelan, Andrew S. Artz, Jeffery J. Auletta, Amy K. Keating, Anil Sapru, Bipin N. Savani, Richard F. Olsson, Peiman Hematti, Christine Duncan, Brent R. Logan, David I. Marks, Staci D. Arnold, Robert Peter Gale, Christopher C. Dvorak, Eva C. Guinan, Celalettin Ustun, Saurabh Chhabra, Matt S. Zinter, Allistair Abraham, Kirsten M. Williams
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 26, iss 2
Biol Blood Marrow Transplant
Biol Blood Marrow Transplant
Critically ill pediatric allogeneic hematopoietic cell transplant (HCT) patients may benefit from early and aggressive interventions aimed at reversing the progression of multiorgan dysfunction. Therefore, we evaluated 25 early risk factors for pedia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b17badb9d45b647ef652cc536ec83c36
https://escholarship.org/uc/item/6q32s3tb
https://escholarship.org/uc/item/6q32s3tb
Publikováno v:
Blood. 138:3681-3681
BACKGROUND Myelodysplastic syndromes (MDS) represent a heterogeneous group of myeloid malignancies characterized by cytopenia and increased risk of progression to acute myeloid leukemia (AML) driven by accumulated somatic mutations in hematopoietic s